Cargando…
A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most aggressive primary tumor of the central nervous system. As biomedicine advances, the researcher has found the development of GBM is closely related to immunity. In this study, we evaluated the GBM tumor immunoreactivity and defined the Immune-High (IH) and I...
Autores principales: | Gao, Ming, Wang, Xinzhuang, Han, Dayong, Lu, Enzhou, Zhang, Jian, Zhang, Cheng, Wang, Ligang, Yang, Quan, Jiang, Qiuyi, Wu, Jianing, Chen, Xin, Zhao, Shiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874158/ https://www.ncbi.nlm.nih.gov/pubmed/33584801 http://dx.doi.org/10.3389/fgene.2020.604655 |
Ejemplares similares
-
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020) -
A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021) -
A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA
por: Zhang, Dongzhi, et al.
Publicado: (2021) -
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020) -
Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)